Loss of hydroxymethylcytosine is an independent adverse prognostic factor in clear cell Renal Cell Carcinoma (ccRCC) and can be abrogated by ascorbic acid mediated TET activation
收藏NIAID Data Ecosystem2026-04-25 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP175163
下载链接
链接失效反馈官方服务：
资源简介：
The experiment was performed to study high resolution gene specific changes induced by Ascorbic acid tretament in clear cell RCC cells (786-0 cell line) Overall design: 786-O ccRCC cells were treated either with control (catalase) or with catalase+ ascorbic acid. BS and OxBS were performed in both.
创建时间：
2019-09-24
